Dolor Remedies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 4.50 M
- Revenue Growth 22.56%
- Profit Growth -65.85%
- Ebitda -26.18%
- Net Worth 4.34%
- Total Assets 11.21%
About Dolor Remedies
Dolor Remedies Private Limited (DRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 May 2008 and has a history of 16 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.50 M.
Jhuma Choudhary and Avinandan Choudhary serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397DL2008PTC177746
-
Company No.
177746
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 May 2008
-
Date of AGM
27 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Dolor Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jhuma Choudhary
|
Director | 07-May-2008 | Current |
|
Avinandan Choudhary
|
Additional Director | 26-Feb-2021 | Current |
Financial Performance of Dolor Remedies.
Dolor Remedies Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 22.56% increase. The company also saw a substantial fall in profitability, with a 65.85% decrease in profit. The company's net worth moved up by a moderate rise of 4.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dolor Remedies?
In 2019, Dolor Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Formis Health Technologies Private LimitedAvinandan Choudhary is a mutual person
-
Breathwork Healthcare Private LimitedAvinandan Choudhary is a mutual person
Charges (Loans)
₹4.50 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.45 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jun 2015 | Hdfc Bank Limited | ₹4.50 M | Open |
How Many Employees Work at Dolor Remedies?
Unlock and access historical data on people associated with Dolor Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dolor Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolor Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
